Welcome to our dedicated page for Xylo Technologies SEC filings (Ticker: XYLO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Tracking disclosures for a company that juggles incision-less surgical tools, e-commerce traffic engines, and electric-vehicle safety systems isn’t easy. XYLO’s SEC documents often exceed 250 pages, mixing FDA milestones for its MUSE GERD device with revenue from online advertising affiliates. If you have ever asked, “How do I read XYLO’s annual report 10-K?” or “Where can I monitor XYLO insider trading Form 4 transactions in real time?”, this page was built for you.
Stock Titan’s AI-powered analysis converts dense filings into plain-language briefs. Open a 10-Q and our engine tags the segment that shows whether medical-device sales outpaced the digital-commerce unit. Get instant alerts on “XYLO quarterly earnings report 10-Q filing” and see key metrics side-by-side with prior quarters. Form 4 insider data are streamed the moment executives trade—search “XYLO Form 4 insider transactions real-time” and you’ll land here first.
Every filing type is covered and explained simply: the annual report—searchable as “XYLO annual report 10-K simplified”—breaks out R&D spend on ultrasonic stapling; 8-K material events explained detail joint ventures on drone safety; the proxy statement reveals executive compensation structures for those comparing “XYLO proxy statement executive compensation”. Our platform answers real investor questions: How are equity stakes in EV robotics recorded? Which directors bought shares last week? What risk factors are new? Instead of wading through PDFs, use our AI summaries, comparative tables, and keyword search to grasp the story faster and make confident decisions.
L.I.A. Pure Capital Ltd. and CEO Kfir Silberman have filed Amendment No. 5 to their Schedule 13D regarding Xylo Technologies. The filing discloses significant developments in their ownership position and a major corporate transaction:
Key details:
- The reporting persons currently own 2,980,000 ordinary shares (74,500 ADSs), representing 5.81% of outstanding shares
- On June 22, 2025, the Tel Aviv district court approved an arrangement for Pure Capital to acquire all remaining shares of Xylo Technologies
- The arrangement must be completed within 180 days of court approval
- Upon completion, Xylo will become a wholly-owned subsidiary of Pure Capital
- The company will subsequently delist from Nasdaq and terminate its public company obligations
Recent transactions include purchases of 1,000 ADSs at $5.004 on June 18 and 1,000 ADSs at $4.986 on June 20, 2025. Total investment in shares amounts to approximately $314,500.
Xylo Technologies Ltd. ("XYLO") reported that the Tel Aviv District Court (Economic Division) approved the previously disclosed Section 350 Arrangement on 22 June 2025. The Arrangement, already endorsed by shareholders on 27 May 2025, must be completed within 180 days (by mid-December 2025).
Under the Arrangement, L.I.A. Pure Capital Ltd. will acquire all XYLO shares it does not currently hold, turning XYLO into its wholly-owned subsidiary. Upon closing, XYLO’s American Depositary Shares will be delisted from Nasdaq and the company will cease to have U.S. public-company reporting obligations. Management will provide further scheduling and procedural updates as they become available.
The filing includes customary forward-looking-statement disclaimers and notes that this Form 6-K is incorporated by reference into several outstanding shelf and equity incentive registration statements.